ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $353,782 | -95.5% | 12,370 | -89.7% | 0.00% | -99.1% |
| Q4 2021 | $7,927,000 | +6.2% | 119,565 | +0.0% | 0.11% | -4.2% |
| Q3 2021 | $7,464,000 | -14.9% | 119,562 | +12.9% | 0.12% | -15.6% |
| Q2 2021 | $8,772,000 | +16.3% | 105,920 | -6.9% | 0.14% | -4.7% |
| Q1 2021 | $7,545,000 | -14.6% | 113,788 | -1.1% | 0.15% | -15.4% |
| Q4 2020 | $8,831,000 | +1006.6% | 115,090 | +521.2% | 0.18% | +169.2% |
| Q3 2020 | $798,000 | +14.5% | 18,526 | +14.8% | 0.06% | 0.0% |
| Q2 2020 | $697,000 | – | 16,135 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |